LexDanaLexDanabeta
Inventor

Tim Beaumont

Inventor
Ouderkerk aan de Amstel, NL

Overview

27→
Patents
2013–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 27 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides32%
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
C12NMicroorganisms or enzymes5%
B60PVehicles adapted for load transportation or to transport, to carry, or to comprise special loads or objects2%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%
PatentTitleYear
10,730,931RSV-specific binding molecules and means for producing them202010,723,786RSV-specific binding molecule202010,556,963Means and methods for counteracting myeloproliferative or lymphoproliferative disorders202010,435,463Hepatitis C virus specific antibody201910,344,076Means and methods for producing high affinity antibodies201910,273,454Means and methods for influencing the stability of antibody producing cells201910,059,757RSV-specific binding molecules and means for producing them201810,035,843RSV-specific binding molecule201810,017,562RSV G protein specific antibodies20189,969,795Means and methods for producing high affinity antibodies20189,927,428'Gram-positive bacteria specific binding compounds'20189,822,339'Means and methods for influencing the stability of antibody producing cells'20179,718,874'Influenza A virus specific antibodies'20179,718,876'RSV G protein specific antibodies'20179,688,745'Gram-positive bacteria specific binding compounds'20179,458,228'Gram-positive bacteria specific binding compounds'20169,399,673'Gram-positive bacteria specific binding compounds'20169,321,831'RSV-specific binding molecules and means for producing them'20169,283,274'RSV specific binding molecule'20169,273,118'Means and methods for producing high affinity antibodies'20169,266,943'Gram-positive bacteria specific binding compounds'20169,206,247'Means and methods for producing high affinity antibodies'20159,127,251'Means and methods for influencing the stability of antibody producing cells'20159,090,677'Gram-positive bacteria specific binding compounds'20158,617,556'Gram-positive bacteria specific binding compounds'20138,568,726'RSV specific binding molecule'20138,562,996'RSV-specific binding molecules and means for producing them'2013

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2013–2020Patents assigned to AIMM THERAPEUTICS BV (19)· patent assignee history
2013–2020Patents assigned to MEDIMMUNE LTD (8)· patent assignee history
2013–2017Patents assigned to BEAUMONT TIM (7)· patent assignee history
2013–2018Patents assigned to GENENTECH INC (7)· patent assignee history
2013–2017Patents assigned to SPITS HERGEN (5)· patent assignee history
2013–2020Based in Ouderkerk aan de Amstel, NL· patent location history
2013Based in Amstel, NL· patent location history
2017–2020Based in Amsterdam Zuidoost, NL· patent location history
2017Based in Amsterdam, NL· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AIMM THERAPEUTICS BV192013–2020
MEDIMMUNE LTD82013–2020
BEAUMONT TIMself72013–2017
GENENTECH INC72013–2018
SPITS HERGEN52013–2017
Locations
LocationPatentsSpan
Ouderkerk aan de Amstel, NL202013–2020
Amsterdam Zuidoost, NL52017–2020
Amsterdam, NL12017
Amstel, NL12013